Close
ACHEMA MIDDLE EAST 2026

Novavax and Israel Announce Advance Purchase Agreement for Supply of COVID-19 Vaccine

Novavax, Inc., a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, and Israel's Ministry of Health announced an agreement...

Cryoport and Cell Matters Enter into Strategic Partnership

Cryoport, Inc., a global leader in temperature-controlled supply chain solutions for the life sciences industry, announced that it has entered into a strategic partnership...

Sharp invests in new gene therapy packaging and distribution capacity at EU Heerenveen facility

Sharp, a global leader in contract packaging and clinical supply services, has completed the construction of new purpose-built production suites to facilitate the packaging,...

Evotec enters iPSC-based drug discovery partnership with Boehringer Ingelheim in ophthalmology

Evotec announced that the Company has entered a target and drug discovery partnership with Boehringer Ingelheim, focusing on induced pluripotent stem cell (“iPSC”)-based disease...

Gilead Sciences Announces FDA Approval of Veklury for Treatment of Non-Hospitalized Patients at High Risk for COVID-19

Gilead Sciences, Inc. announced that the U.S. FDA has granted expedited approval of a supplemental new drug application (sNDA) for Veklury® (remdesivir) for the...

EC Approves Merck’s KEYTRUDA as Adjuvant Therapy for Certain Patients With Renal Cell Carcinoma Following Surgery

Merck, known as MSD outside the United States and Canada, announced that the EC has approved KEYTRUDA, Merck’s anti-PD-1 therapy, as monotherapy for the...

Moderna and Carisma Establish Collaboration to Develop in vivo Engineered Chimeric Antigen Receptor Monocytes for Oncology

Moderna Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Carisma Therapeutics Inc., a biopharmaceutical pioneer in engineered macrophage-based therapeutics, announced...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...